[1] Centers for Disease Control and Prevention. Scarlet fever: a group A streptococcal infection. http://www.cdc.gov/Features/ScarletFever.
[2] Dong H, Xu G, Li S, et al. Beta-haemolytic group A streptococci emm75 carrying altered pyrogenic exotoxin A linked to scarlet fever in adults [J].Journal of Infection, 2008, 56(4):261-267.
[3] Lau EHY, Hiroshi N, Cowling BJ, et al. Scarlet Fever Outbreak, Hong Kong,2011[J].Emerging Infectious Diseases,2012,18(10):1700-1702.
[4] World Health Organization. Scarlet fever, http://www.wpro.who.int/china/mediacentre/factsheets/scarlet_fever/zh/.
[5] China Disease Prevention and Control Bureau. National legal infectious disease epidemic situation, http://www.nhc.gov.cn/jkj/new_index.shtml.
[6] Kirby RS, Delmelle E, Eberth JM. Advances in spatial epidemiology and geographic information systems[J]. Annals Epidemiol,2017,27(1):1-9.
[7] Cromley EK.GIS and disease. Ann Rev Public Health,2003,24:7-24.
[8] Tami A, Grillet ME, Grobusch MP. Applying geographical information systems(GIS) to arboviral disease surveillance and control: a powerful tool[J].Travel Med Infect Dis,2016,14(1):9-10.
[9] Zhang Q, Liu W, Ma W, et al. Spatiotemporal epidemiology of scarlet fever in Jiangsu Province, China, 2005-2015[J]. BMC Infectious Diseases,2017,17(1):596-602.
[10] Gehendra M, Chao W, Da H, et al. Spatiotemporal Pattern Analysis of Scarlet Fever Incidence in Beijing, China, 2005–2014[J]. International Journal of Environmental Research and Public Health, 2016, 13(1):131-148.
[11] Qingfeng Shao, Ye Chen, Ying Lu. Epidemiological characteristics of scarlet fever in Shenyang from 2005 to 2012 [J].Journal of Strait Preventive Medicine,2014,20(6):31-32.
[12] Xuemei Yang, Shan Bai. Epidemic trend analysis of scarlet fever in Shenyang from 2004 to 2009[J]. Occupation and health, 2011, 27(4):439-441.
[13] Mengyang Dai. Epidemic characteristics of scarlet fever in Shenyang from 2004 to 2012 [J].Occupation and health, 2014,30(10):1361-1362.
[14] Mengyang Dai, Chunqing Zhang. Epidemiological characteristics of scarlet fever in Shenyang from 2013 to 2017[J].Forum on Preventive Medicine, 2018, 24(09):52-53.
[15] SMBS. Shenyang Municipal Bureau of Statistics. Available online: http://tjj.shenyang.gov.cn/web/tjnianjian/2018sy/nrll.htm.
[16] National Health Commission of the People's Republic of China. Scarlet fever diagnostic criteria,2008.http://www.nhc.gov.cn/wjw/s9491/200802/38805.shtml.
[17] National Health Commission of the People's Republic of China. Incidence of Notifiable Infectious Disease in China. Available online: http://www.nhc.gov.cn/.
[18] GIS Geography. Spatial Autocorrelation and Moran’s I in GIS. Available online: https://gisgeography.com/spatial-autocorrelation-moran-i-gis/ .
[19] Saxena R, Nagpal BN, Das MK, et al. A spatial statistical approach to analyze malaria situation at micro level for priority control in Ranchi district, Jharkhand[J]. Indian Journal of Medical Research, 2012, 136(5):776-782.
[20] Liu Y, Chan TC, Yap LW, et al. Resurgence of scarlet fever in China: a 13-year population-based surveillance study. Lancet Infectious Diseases,2018(8):903-912.
[21] Andrey DO, Posfay-Barbe KM. Re-emergence of scarlet fever: old players return. Expert Review of Anti-Infective Therapy,2014(8):687-689.
[22] Luk EY, Lo JY, Li AZ, etal. Scarlet fever epidemic, Hong Kong, 2011. Emerging Infectious Diseases, 2012(10):1658-1661.
[23] Kim JH, Cheong HK. Increasing number of scarlet fever cases, South Korea, 2011-2016.Emerging Infectious Diseases,2018,24(1):172-173.
[24] Brockmann SO, Eichner L, Eichner M. Constantly high incidence of scarlet fever in Germany. Lancet Infectious Diseases,2018(5):499-500.
[25] Lamagni T, Guy R, Chand M, et al. Resurgence of scarlet fever in England, 2014-2016: a population-based surveillance study. Lancet Infectious Diseases,2018(2):180-187
[26] Mahara G, Chhetri JK, Guo X, et al. Increasing prevalence of scarlet fever in China[J].BMJ. 2016, 353: i2689.
[27] Choi JH, Yang NR, Lee WJ, et al. Distribution of emm types among group a streptococcus isolates from children in Korea. Diagnostic Microbiol Infect Dis. 2015;82(1):26–31.
[28] Turner CE, Pyzio M, Song B, et al. Scarlet fever upsurge in England and molecular-genetic analysis in north-West London, 2014. Emerg Infect Dis. 2016;22(6):1075–8.
[29] Guy R, Williams C, Irvine N , et al. Increase in scarlet fever notifications in the United Kingdom, 2013/2014. Euro Surveill. 2014,19(12):20749.
[30] Zhang T, Yin F, Zhou T, et al. Multivariate time series analysis on the dynamic relationship between Class B notifiable diseases and gross domestic product (GDP) in China[J].Scientific Reports,2016,6(1):29.
[31] Wang Y, Xu C, Wang Z, et al. Seasonality and trend prediction of scarlet fever incidence in mainland China from 2004 to 2018 using a hybrid SARIMA-NARX model.PeerJ,2019,7:e6165.
[32] You Y, Davies MR, Protani M, et al. Scarlet Fever Epidemic in China Caused by Streptococcus pyogenes Serotype M12: Epidemiologic and Molecular Analysis[J].EBioMedicine,2018,28(C):128-135.
[33] Wu SS, Ma CN, Peng XM, et al. Characteristics on the onset features of scarlet fever in Beijing,2006-2015[J]. Chinese Journal of epidemiology,2017,38(4):514-517.
[34] Gehendra M, Chao W, Kun Y, et al. The Association between Environmental Factors and Scarlet Fever Incidence in Beijing Region: Using GIS and Spatial Regression Models[J].International Journal of Environmental Research and Public Health,2016,13(11):1083-1098.
[35] World Health Organization. Western Pacific Region. Scarlet Fever: Factsheet of Scarlet Fever in China. Available online:http://www.wpro.who.int/china/mediacentre/factsheets/scarlet_fever/en/.
[36] Public Health England, United Kingdom. Scarlet Fever: Second Year of High Activity. Available online: https://www.gov.uk/government/news/scarlet-fever-second-year-of-high-activity.
[37] Wong SS, Yuen KY. Streptococcus pyogenes and re-emergence of scarlet fever as a public health problem[J]. Emerging Microbes and Infections,2012,1(7):e2.